acalabrutinib maleate

acalabrutinib · AstraZeneca AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for acalabrutinib maleate, covering 2026-07-06 to 2026-07-06. Get the full timeline:

Most recent: EMA Authorised: Calquence (acalabrutinib;acalabrutinib maleate) — AstraZeneca AB